Date: 1nd November
Days old: 4479
Time: 2PM London/10AM New York
Update and overview of new clinical studies in diabetes and influence on future research and treatment
Comprehensive update and overview of new clinical studies in diabetes and how the results from these studies will influence future research and treatment of diabetes.
Dr. Fonseca will review the important clinical trials conducted in diabetic patients in the past couple of years thus providing an overview of the currently important new insights in the field. Important drug classes and results from these studies will be presented and commented including SGLT-2 inhibitors, GLP-1 analogues, new insulins, weight loss drugs and novel anti-inflammatory approaches. Both efficacy outcomes and safety/tolerability issues will be discussed extensively. Dr. Fonseca will also touch on the latest treatment recommendations for Type 2 diabetes.
This webinar will be a condensed update and lecture on Type 2 diabetes for anyone working in the field delivered by one of the authoritative voices in the field.
Presented by
Vivian A. Fonseca, MD, FRCP,
Tullis-Tulane Alumni Chair in Diabetes, Professor of Medicine and Chief of the Sction of Endocrinology, Tulane University Medical Center
Vivian A. Fonseca, MD, FRCP, is Professor of Medicine, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is currently President for Science and Medicine of the American Diabetes Association. Dr. Fonseca has served on and been chairman of the clinical practice committee of the American Diabetes Association, the ADA Disaster Task Force, ADA strategic planning committee and the joint ADA/ACC "Make the Link" Program. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease.
Hans-Peter Guler, MD,,
Senior Vice President, Clinical Development, Cardiovascular and Endocrinology, INC Research
Hans-Peter Guler, MD is Senior Vice President, Clinical Development, Cardiovascular and Endocrinology at INC Research. He has 20+ years of experience in clinical research. Prior to joining INC Research, Dr. Guler served as Chief Medical Officer/VP Clinical Development at Phenomix for six years. He also has held senior positions with Regeneron Pharmaceuticals, Chiron Corp. and Ciba-Geigy Corp. His work in clinical research includes studies at all stages in indications including diabetes mellitus, obesity, rheumatoid arthritis, hepatitis C, asthma, sepsis, cardiovascular disease, and renal failure.
Download Slides
Please login to download the slidesKey Learning Objectives
- Understanding recent diabetes trials and their implications for medical practice and how results from these trials drive the currently ongoing and future studies
- Building better informed drug development teams
- Managing and planning future trials with key insights from these published studies in mind thus reducing risk
Audience
- Chief Medical Officers
- Medical Directors
- Directors of Clinical Operations
- Other operational staff
- Clinical Development Specialists
- Clinical Research Scientists
- Business Development Staff
- Regulatory Directors and Staff